IP Library Granted Patent US 9,469,655
Granted Patent B2
US 9,469,655 · App. 14/660,050 · Granted Oct 18, 2016

Methods for the acylation of maytansinol

Inventors: Wayne C. Widdison (Belmont, MA); Robert Yongxin Zhao (Lexington, MA)
Assignee: ImmunoGen, Inc.
C07D498/16C07D498/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,469,655
App. No.
14/660,050
Granted
Oct 18, 2016
Kind
B2
Abstract

Disclosed is a method of preparing an amino acid ester of maytansinol by reacting maytansinol with an N-carboxyanhydride of an amino acid (NCA) in the presence of a drying agent. Also disclosed is an improved method of preparing an amino acid ester of maytansinol in which a nucleophile is added to the reaction mixture after completion of the reaction between maytansinol and an N-carboxyanhydride of an amino acid.

Claims (34)

1. A method of preparing a compound represented by the following formula:

wherein R 1 is methyl; and R 2 is methyl, the method comprising:

reacting maytansinol with an N-carboxyanhydride in a reaction mixture additionally comprising a base, a drying agent and a Lewis acid, wherein the N-carboxyanhydride is represented by the following formula:

thereby forming the compound of Formula (I).

2. The method of claim 1 , wherein the compound of Formula (I) is represented by the following formula:

and the N-carboxyanhydride is represented by the following formula:

3. The method of claim 2 , wherein the Lewis acid is selected from the group consisting of zinc triflate, zinc chloride, magnesium bromide, magnesium triflate, copper triflate, copper (II) bromide, copper (II) chloride, and magnesium chloride.

4. The method of claim 2 , wherein the Lewis acid is zinc triflate.

5. The method of claim 1 , further comprising contacting the reaction mixture, after the reaction of maytansinol and the N-carboxyanhydride, with an aqueous solution containing bicarbonate or carbonate, or contacting the reaction mixture with a metal scavenger.

6. A method of preparing a compound represented by the following formula:

wherein R 1 is methyl; and R 2 is methyl, the method comprising:

a) reacting maytansinol with an N-carboxyanhydride in a reaction mixture additionally comprising a base and a Lewis acid, wherein the N-carboxyanhydride is represented by the following formula:

thereby forming the compound of Formula (I);

b) reacting unreacted N-carboxyanhydride from the reaction mixture in step a) with a nucleophilic reagent.

7. The method of claim 6 , wherein the compound of Formula (I) is represented by the following formula:

and the N-carboxyanhydride is represented by the following formula:

8. The method of claim 7 , wherein the Lewis acid is selected from the group consisting of zinc triflate, zinc chloride, magnesium bromide, magnesium triflate, copper triflate, copper (II) bromide copper (II) chloride, and magnesium chloride.

9. The method of claim 8 , wherein the Lewis acid is zinc triflate.

10. The method of claim 6 , wherein the reaction mixture in step a) further comprises a drying agent.

11. The method of any one of claims 6 , 7 , and 8 - 10 , wherein the nucleophilic reagent is water or an alcohol.

12. The method of claim 11 , wherein the alcohol is methanol, ethanol, n-propanol, isopropanol, or tert-butanol.

13. The method of claim 6 , wherein the method further comprises contacting the reaction mixture after step b) with an aqueous solution containing bicarbonate or carbonate, or contacting the reaction mixture with a metal scavenger.

14. The method of claim 1 or 6 , further comprising the step of reacting the compound of formula (I) with a carboxylic acid having the formula R 3 COOH in the presence of a condensing agent, or with an activated carboxylic acid having the formula R 3 COX, to form a compound represented by the following formula:

wherein R 3 is —Y—S—SR 4 , Y is C 1 -C 10 alkylene, R 4 is C 1 -C 10 alkyl, aryl, or heteroaryl,

X is a halide, an alkoxy group, an aryloxy group, an imidazole, —S-phenyl optionally substituted with nitro or chloride, or —OCOR, in which R is a linear C 1 -C 10 alkyl group, a branched C 1 -C 10 alkyl group, a cyclic C 3 -C 10 alkyl group, or a C 1 -C 10 alkenyl group, and,

—COX is a reactive ester.

15. The method of claim 14 , wherein Y is —CH 2 CH 2 — or —CH 2 CH 2 C(CH 3 ) 2 —, and R 4 is —CH 3 .

16. The method of claim 15 , further comprising reacting the compound of formula (III) with a reducing agent to form a compound represented by the following formula:

17. The method of claim 14 , wherein the condensing agent is a carbodiimide, a uronium, an active ester, a phosphonium, 2-alkyl-1-alkylcarbonyl-1,2-dihydroquinoline, 2-alkoxy-1-alkoxycarbonyl-1,2-dihydroquinoline, or alkylchloroformate.

18. The method of claim 17 , wherein the condensing agent is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride.

19. The method of claim 1 , 2 , 3 , 4 , 5 , 6 , 7 , or 8 , wherein the base is a trialkylamine, a metal alkoxide, an alkyl metal, an aryl metal, a metal hydride, a metal amide, or a silicon-based amide.

20. The method of claim 19 , wherein the trialkylamine is diisopropylethylamine.

21. The method of any one of claims 1 , 2 , 3 , 4 , and 10 , wherein the drying agent is a molecular sieve, sodium sulfate, calcium sulfate, calcium chloride, or magnesium sulfate.

22. The method of claim 21 , wherein the drying agent is a molecular sieve.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Feb 12, 2024
From: BIOPHARMA CREDIT PLC
To: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
Reel/Frame 066553/0109 →
PATENT SECURITY AGREEMENT Recorded Apr 6, 2023
From: IMMUNOGEN, INC.; IMMUNOGEN SWITZERLAND GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 063282/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2015
From: WIDDISON, WAYNE C.; ZHAO, ROBERT YONGXIN
To: IMMUNOGEN, INC.
Reel/Frame 035490/0886 →
Continuity (3)
Continuation 14037657 · Sep 26, 2013
Provisional Application 61705731 · Sep 26, 2012
Related Publication 20150191488A1 · Jul 9, 2015